TriSalus Life Sciences, Inc. (TLSI) Operating cash flow 2021–2025
TriSalus Life Sciences, Inc. (TLSI) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$18.0MFY2025 · since FY2021: -$1.7M → -$18.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$18.0M | +55.9% |
| FY2024 | -$40.8M | +19.2% |
| FY2023 | -$50.6M | -56.5% |
| FY2022 | -$32.3M | -1759.1% |
| FY2021 | -$1.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TLSI financial trends
TLSI RevenueTLSI Net incomeTLSI Net marginTLSI Gross profitTLSI Gross marginTLSI Operating incomeTLSI Operating marginTLSI Free cash flowTLSI Capital expendituresTLSI Return on equityTLSI Stock buybacksTLSI Dividends paidTLSI Total assetsTLSI Total liabilitiesTLSI Shareholders’ equityTLSI overview →